C2sense offers algorithmic software that enhances the sensitivity and specificity of point‑of‑care and at‑home diagnostic assays without changing the underlying chemistry. Their platform detects hundreds to thousands of targets at single‑copy sensitivity in under three hours using standard lab equipment, delivering up to ten‑fold sensitivity gains and rapid false‑positive mitigation. Custom analytical solutions are typically deployed within a week, helping test manufacturers improve performance and accelerate time‑to‑market.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnostic assays for point‑of‑care and at‑home testing often suffer from limited sensitivity and specificity, leading to false‑positive results, non‑specific binding, and assay failures that require costly redesigns or additional validation steps.
Solution
C2sense provides algorithmic and software enhancements that analyze assay data to identify and correct false positives, non‑specific binding, and other defects without altering the underlying chemistry. Their platform enables simultaneous detection of hundreds to thousands of targets at single‑copy sensitivity, delivering results in under three hours using existing laboratory equipment. By integrating these algorithms, test developers can achieve up to ten‑fold sensitivity improvements and higher specificity, accelerating time‑to‑market and reducing the need for extensive assay re‑engineering. Custom solutions are delivered within a week, allowing rapid iteration and scaling of diagnostic offerings.
Target Audience
Primary customers are manufacturers and developers of point‑of‑care and at‑home diagnostic tests seeking to improve assay performance and multiplexing capacity.
Features
- Real‑time data processing that flags false positives and non‑specific binding events
- Algorithms that compensate for assay defects, enhancing overall performance without redesign
- Multiplex capability to detect hundreds‑to‑thousands of targets in a single run
- Single‑copy detection sensitivity achieved in less than three hours
- Compatibility with standard laboratory instruments and existing assay workflows
- Rapid deployment of custom analytical solutions, typically within one week
- Demonstrated average ten‑fold increase in assay sensitivity across tested platforms